What does EP1169038 cover, and who is it about?
The information provided does not include the contents of EP1169038 (what invention it claims, the assignee/applicant, or the drug/formulation/mechanism it covers). Without the patent’s bibliographic record (title, assignee, priority dates, and claim scope), I can’t accurately describe what EP1169038 relates to beyond your mention of dasatinib.
When does the EP1169038 dasatinib patent expire?
Expiration depends on the patent’s filing/priority dates and whether any extensions apply. With no priority or filing date included in the prompt, I can’t calculate an expiry date for EP1169038.
How does EP1169038 relate to dasatinib (Sprycel)?
EP1169038 could be relevant to dasatinib depending on what it claims (e.g., specific compounds, formulations, dosing regimens, or use). But the prompt does not include the patent title, abstract, or claims, so I can’t verify the linkage.
Can you still use dasatinib patents after EP1169038 expires?
Even after one patent expires, other patents in the same product family (process patents, polymorph/formulation patents, second medical-use patents, and related EP/WO family members) can still restrict certain manufacture, sale, or indications. To answer this for dasatinib, I’d need the specific EP1169038 family details and which jurisdictions are covered.
What to check in the EP register to confirm scope and expiry
If you look up EP1169038 in Espacenet/INPADOC or the EP register, the key items to confirm are:
- Title/abstract and assignee (to confirm it’s actually about dasatinib and what it covers)
- Priority date(s) (drives the baseline 20-year term for many patents)
- Grant status and legal events (e.g., withdrawal, lapse, or limitation)
- Whether any supplementary protection certificates (SPCs) or pediatric extensions apply in the specific EU country (SPCs are country-specific and depend on marketing authorization timing)
If you share the patent record, I can answer precisely
Paste any of the following and I’ll determine the scope, relevance to dasatinib, and likely expiry:
- EP1169038 title and assignee
- priority date(s)
- whether it was granted (and grant/publication numbers)
- any link to the Espacenet/official register page you’re using
Sources
No sources were provided in the prompt.